There is no current role for molecular phenotyping in metastatic castrate-resistant prostate cancer.

There is no current role for molecular phenotyping in metastatic castrate-resistant prostate cancer. Clin Adv Hematol Oncol. 2015 Sep;13(9):580-5 Authors: Vogelzang NJ PMID: 26452189 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research